-
CH 223191: AhR Antagonist for Toxicology
2026-08-14
CH 223191 is a potent aryl hydrocarbon receptor antagonist that suppresses ligand-driven AhR transcription and provides a practical tool for dioxin toxicity mechanism study. In mouse ovarian antral follicles, 1 μM CH 223191 partially rescued MEHP-associated growth, hormone, and gene-expression changes.
-
0.4% Trypan Blue Solution: Practical QC Guide
2026-08-14
0.4% Trypan Blue Solution provides a rapid membrane-integrity readout for cell viability measurement, live/dead cell discrimination, and research cell counting. It is suitable for cell culture and cytotoxicity workflows, but it is not a diagnostic reagent or a standalone method for identifying early apoptosis or specific cell-death mechanisms.
-
BCL-2 Targeting Across Heterogeneous CRPC
2026-08-13
A 2026 study integrates single-cell imaging, mechanistic experiments, therapeutic modeling, and a Phase Ib trial to identify BCL-2 as a shared vulnerability across diverse castration-resistant prostate cancer states. Its findings show that androgen receptor pathway inhibition can increase BCL-2-positive populations, supporting combined AR and BCL-2 targeting rather than an AR-centric strategy alone.
-
GI 254023X: A Causal Assay Framework
2026-08-13
GI 254023X is a selective ADAM10 inhibitor for dissecting sheddase-dependent signaling and endothelial barrier injury. This article develops a causal, cross-assay framework that connects biochemical selectivity with Notch1 signaling, VE-cadherin protection, and evidence-based dose decisions.
-
SAF312 and TRPV1 in Ocular Surface Pain
2026-08-12
The reference study presents SAF312 (Libvatrep) as a potent, selective, noncompetitive TRPV1 antagonist with ocular surface exposure and an acceptable preclinical safety profile. Its integrated pharmacology, pharmacokinetic, toxicology, and corneal wound-healing data support further investigation of localized TRPV1 blockade for ocular surface pain without assuming clinical efficacy.
-
Adefovir (GS-0393) Research Workflows
2026-08-12
Adefovir (GS-0393) combines a defined HBV DNA polymerase mechanism with utility as an OAT1 transporter probe. This guide translates those properties into practical antiviral, renal transport, and translational safety workflows with concentration-aware troubleshooting.
-
KX2-391 Dihydrochloride: Assay Logic
2026-08-11
KX2-391 dihydrochloride is a dual-mechanism Src and tubulin inhibitor with applications spanning oncology, HBV research, and BoNT/A studies. This guide focuses on assay design, evidence boundaries, and how to interpret its distinct cellular phenotypes.
-
Silymarin Workflows for Translational Bench Research
2026-08-11
Build more reproducible oxidative-stress, liver-cancer, metabolic, and antiviral assays with a mixture-aware workflow for Silymarin. Solvent control, dose-ranging, and orthogonal readouts help distinguish genuine biology from vehicle effects and assay interference.
-
(-)-Epigallocatechin gallate (EGCG) Workflow Guide
2026-08-10
Build more reproducible EGCG studies with controlled dosing, fresh solution handling, orthogonal apoptosis readouts, and interference-aware controls. The workflow also shows how parent EGCG findings can inform cancer chemoprevention, antiviral research, antiangiogenesis, and intracellular bacterial assays without overstating translational maturity.
-
5X Protein Loading Buffer (Reducing) Guide
2026-08-09
5X Protein Loading Buffer (Reducing) supports reducing, denaturing protein sample preparation for conventional SDS-PAGE electrophoresis and molecular-weight-based separation. It should not be used when native complexes, disulfide-linked species, or non-reducing protein conformations must be preserved.
-
EGCG Microgels for Intervertebral Disc Degeneration
2026-08-08
The reference study develops POCM@MCCP, an elastic dual-network hydrogel microsphere that combines EGCG-containing metal-phenolic networks with stimulus-responsive miRNA delivery. Its integrated design sustains cargo release under compression, suppresses inflammatory and oxidative injury, and improves nucleus pulposus cell function in in vitro and in vivo models of intervertebral disc degeneration.
-
Clathrin-Mediated Entry of Type III Grass Carp Reovirus
2026-08-07
Wang et al. used pharmacological inhibition, transmission electron microscopy, and real-time quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, pH-sensitive clathrin-mediated pathway. The lack of inhibition by Latrunculin B is particularly informative: under the tested conditions, viral entry did not require detectable actin filament remodeling, although this conclusion remains specific to the cell model, viral strains, and inhibitor design.
-
Population Pharmacokinetics of Adefovir in Transporter Cockt
2026-08-07
This study applies population pharmacokinetic modeling to clarify how Adefovir behaves as an OAT1 probe in transporter phenotyping cocktails, revealing that co-administration with other drugs alters absorption but leaves renal elimination unchanged. These findings support the continued use of Adefovir as a selective OAT1 probe in clinical pharmacology and transporter research.
-
Chemerin in cNTS Drives Sympathetic Activity via Superoxide
2026-08-06
This study reveals that chemerin acting within the caudal nucleus tractus solitarius (cNTS) elevates sympathetic outflow and blood pressure through a CMKLR1-driven superoxide mechanism. The findings clarify the specific glutamate receptor pathways involved, with implications for dissecting central autonomic regulation.
-
Parathyroid hormone (1-34) (human): Precision in Bone and Ki
2026-08-06
Harness Parathyroid hormone (1-34) (human) for robust, high-fidelity modeling of bone metabolism and renal function. Discover protocol optimizations, troubleshooting guidance, and pivotal advances that set this PTH (1-34) peptide fragment apart for translational research.